Wardelmann E - Search Results

1

Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer.

Perabo FG, Willert PL, Wirger A, Schmidt DH, Wardelmann E, Sitzia M, von Ruecker A, Mueller SC. Perabo FG, et al. Among authors: wardelmann e. Int J Cancer. 2005 Jul 1;115(4):591-8. doi: 10.1002/ijc.20941. Int J Cancer. 2005. PMID: 15704106

2

Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.

Albers P, Ko Y, Wardelmann E, Schmidt D, Adam M, Vetter H, Müller SC. Albers P, et al. Among authors: wardelmann e. Anticancer Res. 2000 May-Jun;20(3B):2107-11. Anticancer Res. 2000. PMID: 10928161

3

Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.

Rhiem K, Klein A, Münch M, Kreutzfeld R, Ramser J, Wardelmann E, Schackert G, Von Deimling A, Wiestler OD, Schmutzler RK. Rhiem K, et al. Among authors: wardelmann e. Int J Cancer. 2003 Aug 10;106(1):74-7. doi: 10.1002/ijc.11169. Int J Cancer. 2003. PMID: 12794759

4

Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors.

Adam M, Schmidt D, Wardelmann E, Wernert N, Albers P. Adam M, et al. Among authors: wardelmann e. Eur Urol. 2003 Sep;44(3):329-36. doi: 10.1016/s0302-2838(03)00262-8. Eur Urol. 2003. PMID: 12932931

5

Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.

Pauls K, Jäger R, Weber S, Wardelmann E, Koch A, Büttner R, Schorle H. Pauls K, et al. Among authors: wardelmann e. Int J Cancer. 2005 Jun 20;115(3):470-7. doi: 10.1002/ijc.20913. Int J Cancer. 2005. PMID: 15700319

6

Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.

Perabo FG, Demant AW, Wirger A, Schmidt DH, Sitia M, Wardelmann E, Müller SC, Kohn EC. Perabo FG, et al. Among authors: wardelmann e. Anticancer Res. 2005 Mar-Apr;25(2A):725-9. Anticancer Res. 2005. PMID: 15868902 Free article.

7

HLA-class II haplotype associations with ovarian cancer.

Kübler K, Arndt PF, Wardelmann E, Krebs D, Kuhn W, van der Ven K. Kübler K, et al. Among authors: wardelmann e. Int J Cancer. 2006 Dec 15;119(12):2980-5. doi: 10.1002/ijc.22266. Int J Cancer. 2006. PMID: 17016821

8

Genetic alterations of HLA-class II in ovarian cancer.

Kübler K, Arndt PF, Wardelmann E, Landwehr C, Krebs D, Kuhn W, van der Ven K. Kübler K, et al. Among authors: wardelmann e. Int J Cancer. 2008 Sep 15;123(6):1350-6. doi: 10.1002/ijc.23624. Int J Cancer. 2008. PMID: 18561316

9

Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.

Friedrichs N, Trautmann M, Endl E, Sievers E, Kindler D, Wurst P, Czerwitzki J, Steiner S, Renner M, Penzel R, Koch A, Larsson O, Tanaka S, Kawai A, Schirmacher P, Mechtersheimer G, Wardelmann E, Buettner R, Hartmann W. Friedrichs N, et al. Among authors: wardelmann e. Int J Cancer. 2011 Oct 1;129(7):1564-75. doi: 10.1002/ijc.25829. Epub 2011 Mar 4. Int J Cancer. 2011. PMID: 21128248

10

SRC inhibition represents a potential therapeutic strategy in liposarcoma.

Sievers E, Trautmann M, Kindler D, Huss S, Gruenewald I, Dirksen U, Renner M, Mechtersheimer G, Pedeutour F, Åman P, Nishio J, Schildhaus HU, Kirfel J, Schirmacher P, Wardelmann E, Buettner R, Hartmann W. Sievers E, et al. Among authors: wardelmann e. Int J Cancer. 2015 Dec 1;137(11):2578-88. doi: 10.1002/ijc.29645. Epub 2015 Jul 6. Int J Cancer. 2015. PMID: 26084847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters